Synta Pharmaceuticals Corp. SNTA today announced that it has
commenced an underwritten public offering of shares of its common stock. The
offering is subject to market and other conditions, and there can be no
assurance as to whether or when the offering may be completed, or as to the
actual size or terms of the offering. Synta intends to grant the underwriters
a 30-day option to purchase additional shares of its common stock.
Jefferies LLC and Cowen and Company, LLC are acting as joint book-running
managers for the proposed offering.
The securities described above are being offered by Synta pursuant to a shelf
registration statement that was previously filed with and declared effective
by the Securities and Exchange Commission (SEC). This press release does not
constitute an offer to sell or a solicitation of an offer to buy the
securities in this offering, nor shall there be any sale of these securities
in any state or other jurisdiction in which such offer, solicitation or sale
would be unlawful prior to the registration or qualification under the
securities laws of any such state or other jurisdiction. A preliminary
prospectus supplement related to the offering will be filed with the SEC and
will be available on the SEC's website located at www.sec.gov. Copies of the
preliminary prospectus supplement and the accompanying prospectus relating to
this offering may be obtained by sending a request to: Jefferies LLC,
Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, 12th
Floor, New York, NY, 10022, by telephone at 877-547-6340, or by email at
Prospectus_Department@Jefferies.com or Cowen and Company, LLC, c/o Broadridge
Financial Services, Attention: Prospectus Department, 1155 Long Island Avenue,
Edgewood, NY 11717, Telephone: 631-274-2806, Fax: 631-254-7140.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in